IBS-C Drugs Market Report

Global and China IBS-C Drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Oct 29, 2022
  • PAGES：181
  • REPORT CODE：GMM1328568
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the IBS-C Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Albireo Pharma Inc

    • Synergy Pharmaceuticals

    • The Menarini Group

    • Catalent Pharmaceuticals Solutions

    • Salix Pharmaceuticals Ltd

    • Ono Pharmaceutical CO LTD

    • Novartis Pharma Ag

    • Sucampo Pharmaceuticals

    • Nestle

    • Prometheus Laboratories Inc

    • Norgine BV

    • Astellas Pharmaceuticals

    • Astrazeneca Plc

    • Actavis Nordic A/S

    • Bama-Geve, SLU

    • Abbott Laboratories

    • Yuhan Corp

    • Ironwood Pharmaceuticals Inc

    • Ardelyx Inc

    • Synthetic Biologics Inc

    • Ferring BV

    • Teva Pharmaceutical Industries

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Linaclotide

    • Lubiprostone

    • Osmotic Laxatives

    • Stimulant Laxatives

    • Other

    Application:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 IBS-C Drugs Industry Overview

      • 1.1.1 IBS-C Drugs Market Scope and Market Segments

      • 1.1.2 IBS-C Drugs Industry Characteristics

      • 1.1.3 Global and China IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China IBS-C Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global IBS-C Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Linaclotide

      • 1.2.2 Lubiprostone

      • 1.2.3 Osmotic Laxatives

      • 1.2.4 Stimulant Laxatives

      • 1.2.5 Other

    • 1.3 Global IBS-C Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Retail Pharmacies

      • 1.3.3 Online Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America IBS-C Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe IBS-C Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC IBS-C Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa IBS-C Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global IBS-C Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global IBS-C Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China IBS-C Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China IBS-C Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global IBS-C Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 IBS-C Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 IBS-C Drugs Industry PEST Analysis

    • 2.3 IBS-C Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 IBS-C Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on IBS-C Drugs Industry

    Chapter 3 Global and China IBS-C Drugs Market, by Manufacturer

    • 3.1 Global and China IBS-C Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China IBS-C Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China IBS-C Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China IBS-C Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China IBS-C Drugs Market Top 3 Players

    Chapter 4 Global and China IBS-C Drugs Market, by Type (2017-2028)

    • 4.1 IBS-C Drugs Market Trend, by Type

    • 4.2 Global IBS-C Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global IBS-C Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global IBS-C Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global IBS-C Drugs Price Trend, by Type (2017-2028)

    • 4.3 China IBS-C Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China IBS-C Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China IBS-C Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China IBS-C Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China IBS-C Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global IBS-C Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global IBS-C Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global IBS-C Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China IBS-C Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China IBS-C Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China IBS-C Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global IBS-C Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China IBS-C Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America IBS-C Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe IBS-C Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC IBS-C Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa IBS-C Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America IBS-C Drugs Market Analysis

    • 7.1 North America IBS-C Drugs Market, by Type

    • 7.2 North America IBS-C Drugs Market, by Application

    • 7.3 North America IBS-C Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe IBS-C Drugs Market Analysis

    • 8.1 Europe IBS-C Drugs Market, by Type

    • 8.2 Europe IBS-C Drugs Market, by Application

    • 8.3 Europe IBS-C Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC IBS-C Drugs Market Analysis

    • 9.1 APAC IBS-C Drugs Market, by Type

    • 9.2 APAC IBS-C Drugs Market, by Application

    • 9.3 APAC IBS-C Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa IBS-C Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa IBS-C Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa IBS-C Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa IBS-C Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina IBS-C Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China IBS-C Drugs Company Profiles

      • 11.1 Albireo Pharma Inc

        • 11.1.1 Albireo Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Albireo Pharma Inc IBS-C Drugs Product Profiles, Application and Specification

        • 11.1.3 Albireo Pharma Inc IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Synergy Pharmaceuticals

        • 11.2.1 Synergy Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Synergy Pharmaceuticals IBS-C Drugs Product Profiles, Application and Specification

        • 11.2.3 Synergy Pharmaceuticals IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 The Menarini Group

        • 11.3.1 The Menarini Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 The Menarini Group IBS-C Drugs Product Profiles, Application and Specification

        • 11.3.3 The Menarini Group IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Catalent Pharmaceuticals Solutions

        • 11.4.1 Catalent Pharmaceuticals Solutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Catalent Pharmaceuticals Solutions IBS-C Drugs Product Profiles, Application and Specification

        • 11.4.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Salix Pharmaceuticals Ltd

        • 11.5.1 Salix Pharmaceuticals Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Salix Pharmaceuticals Ltd IBS-C Drugs Product Profiles, Application and Specification

        • 11.5.3 Salix Pharmaceuticals Ltd IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Ono Pharmaceutical CO LTD

        • 11.6.1 Ono Pharmaceutical CO LTD Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Ono Pharmaceutical CO LTD IBS-C Drugs Product Profiles, Application and Specification

        • 11.6.3 Ono Pharmaceutical CO LTD IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Novartis Pharma Ag

        • 11.7.1 Novartis Pharma Ag Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Novartis Pharma Ag IBS-C Drugs Product Profiles, Application and Specification

        • 11.7.3 Novartis Pharma Ag IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Sucampo Pharmaceuticals

        • 11.8.1 Sucampo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Sucampo Pharmaceuticals IBS-C Drugs Product Profiles, Application and Specification

        • 11.8.3 Sucampo Pharmaceuticals IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Nestle

        • 11.9.1 Nestle Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Nestle IBS-C Drugs Product Profiles, Application and Specification

        • 11.9.3 Nestle IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Prometheus Laboratories Inc

        • 11.10.1 Prometheus Laboratories Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Prometheus Laboratories Inc IBS-C Drugs Product Profiles, Application and Specification

        • 11.10.3 Prometheus Laboratories Inc IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Norgine BV

        • 11.11.1 Norgine BV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Norgine BV IBS-C Drugs Product Profiles, Application and Specification

        • 11.11.3 Norgine BV IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Astellas Pharmaceuticals

        • 11.12.1 Astellas Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Astellas Pharmaceuticals IBS-C Drugs Product Profiles, Application and Specification

        • 11.12.3 Astellas Pharmaceuticals IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Astrazeneca Plc

        • 11.13.1 Astrazeneca Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Astrazeneca Plc IBS-C Drugs Product Profiles, Application and Specification

        • 11.13.3 Astrazeneca Plc IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Actavis Nordic A/S

        • 11.14.1 Actavis Nordic A/S Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Actavis Nordic A/S IBS-C Drugs Product Profiles, Application and Specification

        • 11.14.3 Actavis Nordic A/S IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Bama-Geve, SLU

        • 11.15.1 Bama-Geve, SLU Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Bama-Geve, SLU IBS-C Drugs Product Profiles, Application and Specification

        • 11.15.3 Bama-Geve, SLU IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Abbott Laboratories

        • 11.16.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Abbott Laboratories IBS-C Drugs Product Profiles, Application and Specification

        • 11.16.3 Abbott Laboratories IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Yuhan Corp

        • 11.17.1 Yuhan Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Yuhan Corp IBS-C Drugs Product Profiles, Application and Specification

        • 11.17.3 Yuhan Corp IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Ironwood Pharmaceuticals Inc

        • 11.18.1 Ironwood Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Ironwood Pharmaceuticals Inc IBS-C Drugs Product Profiles, Application and Specification

        • 11.18.3 Ironwood Pharmaceuticals Inc IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Ardelyx Inc

        • 11.19.1 Ardelyx Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Ardelyx Inc IBS-C Drugs Product Profiles, Application and Specification

        • 11.19.3 Ardelyx Inc IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 Synthetic Biologics Inc

        • 11.20.1 Synthetic Biologics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 Synthetic Biologics Inc IBS-C Drugs Product Profiles, Application and Specification

        • 11.20.3 Synthetic Biologics Inc IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Ferring BV

        • 11.21.1 Ferring BV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Ferring BV IBS-C Drugs Product Profiles, Application and Specification

        • 11.21.3 Ferring BV IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.22 Teva Pharmaceutical Industries

        • 11.22.1 Teva Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.22.2 Teva Pharmaceutical Industries IBS-C Drugs Product Profiles, Application and Specification

        • 11.22.3 Teva Pharmaceutical Industries IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 IBS-C Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 IBS-C Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 IBS-C Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global IBS-C Drugs Production Value and Growth Rate (2017-2028)

    • Figure China IBS-C Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global IBS-C Drugs Market Size and Growth Rate of Linaclotide (2017-2028)

    • Figure Global IBS-C Drugs Market Size and Growth Rate of Lubiprostone (2017-2028)

    • Figure Global IBS-C Drugs Market Size and Growth Rate of Osmotic Laxatives (2017-2028)

    • Figure Global IBS-C Drugs Market Size and Growth Rate of Stimulant Laxatives (2017-2028)

    • Figure Global IBS-C Drugs Market Size and Growth Rate of Other (2017-2028)

    • Figure Global IBS-C Drugs Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global IBS-C Drugs Market Size and Growth Rate of Retail Pharmacies (2017-2028)

    • Figure Global IBS-C Drugs Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure North America IBS-C Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe IBS-C Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC IBS-C Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa IBS-C Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global IBS-C Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China IBS-C Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China IBS-C Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China IBS-C Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China IBS-C Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China IBS-C Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China IBS-C Drugs Market Share, by Manufacturer in 2022

    • Table Global IBS-C Drugs Sales Volume, by Type (2017-2028)

    • Table Global IBS-C Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global IBS-C Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global IBS-C Drugs Sales Value, by Type (2017-2028)

    • Table Global IBS-C Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global IBS-C Drugs Price Trend, by Type (2017-2028)

    • Table China IBS-C Drugs Sales Volume, by Type (2017-2028)

    • Table China IBS-C Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China IBS-C Drugs Sales Volume Share, by Type (2017-2028)

    • Table China IBS-C Drugs Sales Value, by Type (2017-2028)

    • Table China IBS-C Drugs Sales Value Share, by Type (2017-2028)

    • Figure China IBS-C Drugs Price Trend, by Type (2017-2028)

    • Table Global IBS-C Drugs Sales Volume, by Application (2017-2028)

    • Table Global IBS-C Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global IBS-C Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global IBS-C Drugs Sales Value, by Application (2017-2028)

    • Table Global IBS-C Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global IBS-C Drugs Sales Value Share, by Application (2017-2028)

    • Table China IBS-C Drugs Sales Volume, by Application (2017-2028)

    • Table China IBS-C Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China IBS-C Drugs Sales Volume Share, by Application (2017-2028)

    • Table China IBS-C Drugs Sales Value, by Application (2017-2028)

    • Table China IBS-C Drugs Sales Value Share, by Application (2017-2028)

    • Figure China IBS-C Drugs Sales Value Share, by Application (2017-2028)

    • Figure China IBS-C Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America IBS-C Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe IBS-C Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC IBS-C Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa IBS-C Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America IBS-C Drugs Sales Volume, by Type (2017-2028)

    • Table North America IBS-C Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America IBS-C Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America IBS-C Drugs Sales Volume, by Application (2017-2028)

    • Table North America IBS-C Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America IBS-C Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe IBS-C Drugs Sales Volume, by Type (2017-2028)

    • Table Europe IBS-C Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe IBS-C Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe IBS-C Drugs Sales Volume, by Application (2017-2028)

    • Table Europe IBS-C Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe IBS-C Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC IBS-C Drugs Sales Volume, by Type (2017-2028)

    • Table APAC IBS-C Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC IBS-C Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC IBS-C Drugs Sales Volume, by Application (2017-2028)

    • Table APAC IBS-C Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC IBS-C Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa IBS-C Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa IBS-C Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa IBS-C Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa IBS-C Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa IBS-C Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa IBS-C Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina IBS-C Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina IBS-C Drugs Sales Value and Growth Rate (2017-2028)

    • Table Albireo Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Albireo Pharma Inc Product Profiles, Application and Specification

    • Table Albireo Pharma Inc IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Synergy Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Synergy Pharmaceuticals Product Profiles, Application and Specification

    • Table Synergy Pharmaceuticals IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table The Menarini Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table The Menarini Group Product Profiles, Application and Specification

    • Table The Menarini Group IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Catalent Pharmaceuticals Solutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Catalent Pharmaceuticals Solutions Product Profiles, Application and Specification

    • Table Catalent Pharmaceuticals Solutions IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Salix Pharmaceuticals Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Salix Pharmaceuticals Ltd Product Profiles, Application and Specification

    • Table Salix Pharmaceuticals Ltd IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ono Pharmaceutical CO LTD Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ono Pharmaceutical CO LTD Product Profiles, Application and Specification

    • Table Ono Pharmaceutical CO LTD IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Pharma Ag Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Pharma Ag Product Profiles, Application and Specification

    • Table Novartis Pharma Ag IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sucampo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sucampo Pharmaceuticals Product Profiles, Application and Specification

    • Table Sucampo Pharmaceuticals IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nestle Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nestle Product Profiles, Application and Specification

    • Table Nestle IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Prometheus Laboratories Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Prometheus Laboratories Inc Product Profiles, Application and Specification

    • Table Prometheus Laboratories Inc IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Norgine BV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Norgine BV Product Profiles, Application and Specification

    • Table Norgine BV IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharmaceuticals Product Profiles, Application and Specification

    • Table Astellas Pharmaceuticals IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astrazeneca Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astrazeneca Plc Product Profiles, Application and Specification

    • Table Astrazeneca Plc IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Actavis Nordic A/S Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Actavis Nordic A/S Product Profiles, Application and Specification

    • Table Actavis Nordic A/S IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bama-Geve, SLU Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bama-Geve, SLU Product Profiles, Application and Specification

    • Table Bama-Geve, SLU IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Yuhan Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Yuhan Corp Product Profiles, Application and Specification

    • Table Yuhan Corp IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ironwood Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ironwood Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Ironwood Pharmaceuticals Inc IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ardelyx Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ardelyx Inc Product Profiles, Application and Specification

    • Table Ardelyx Inc IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Synthetic Biologics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Synthetic Biologics Inc Product Profiles, Application and Specification

    • Table Synthetic Biologics Inc IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ferring BV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ferring BV Product Profiles, Application and Specification

    • Table Ferring BV IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceutical Industries Product Profiles, Application and Specification

    • Table Teva Pharmaceutical Industries IBS-C Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US